TRX2 (trichos=hair in ancient greek; 2=second generation) is one of the world’s leading research projects exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia (AGA). The project has been made possible through Oxford BioLabs Ltd. and former scientists from the University of Oxford, UK. TRX2 follows several independent research paths including:
1) Hair growth
2) The prevention of hair loss
3) A cure against Androgentic Alopecia and other hair growth disorders
TRX2 by Oxford BioLabs Information:
Even though Androgenetic Alopecia is the most common form of hair loss, it is not the only one. There are actually a variety of medical conditions that can cause hair to shed and thin over time. Unexplained hair loss can also be the result of adverse reactions to prescription medication.
In order for any hair loss treatment to be effective, you need to have a proper diagnosis. Before you start a regimen, it is recommended that you consult with your doctor and discuss your symptoms and treatment options.
Prior to meeting with your doctor, it is helpful to familiarize yourself with possible prognoses. To assist in this process, we’ve compiled a list of some of the more common conditions that can cause hair loss.
Alopecia Areata
Alopecia Areata (AA) is an autoimmune disorder that can affect hair on all parts of the body. Although the condition itself is not inherently dangerous, it can adversely affect the psyche of many patients that find it difficult to adapt to the sudden change in appearance. Luckily, 90% of patients diagnosed with Alopecia Areata regain their hair without treatment. Nevertheless, regrowth is slightly more likely in patients that only experience hair loss in a localized area, or are over the age of 40.
So, what is an autoimmune disease? Think of it like this:
Our body is made up of many different types of cells, some of which are programmed to help destroy harmful elements that attack our body. This process is necessary to combat germs and fight disease. Occasionally, however, these cells will instead attack the body they are supposed to protect. This is what we refer to as an autoimmune disorder. In the case of Alopecia Areata, white blood cells destroy hair follicles, causing them to stop producing hair shafts.
Types of Alopecia Areata
Alopecia Areata Monocularis – single patch of hair loss
Alopecia Areata Multilocularis – several patches of hair loss
Alopecia Totalis – all hair on the scalp is lost
Alopecia Universalis – all hair on the scalp and other parts of the body (including eyebrows and eyelashes) is lost
For our ongoing and past research projects please visit our Research page.
Mission & Goal
Our mission is to create an extraordinary customer experience by tackling Androgenetic Alopecia (AGA) through high-performance, cutting-edge science that delivers noticeable, honest results. Our goal is to create the new standard of care for the treatment of AGA.
Company Background
TRX2 is run by Oxford BioLabs. The company was founded in August 2008 by former scientists from the University of Oxford and is incorporated as a Limited Liability Company in England & Wales. The University of Oxford is one of the world’s leading centers for biochemical research and the commercialization of new technologies.
Team
Our team consists of a growing number of
World leading scientists in the field of potassium channel research
Dermatologists and experts in the field of androgentic alopecia
Medical professionals and surgeons
Scientific Lead: Dr. Thomas F.A. Whitfield DPhil
Dr. Whitfield has been an academic visitor at the University of Oxford’s Department of Biochemistry and is an internationally recognized expert in potassium channel research and the molecular mechanism of Androgenetic Alopecia. He is author of multiple peer-reviewed publications and international patents in the field of potassium channel research and Androgenetic Alopecia. Dr. Whitfield holds a DPhil in Biochemistry from the University of Oxford.
Expertise
TRX2 takes advantage of the latest scientific knowledge of the molecular mechanism behind male and female pattern hair loss: The chronic blockage of potassium channels in hair follicles is a cause of hair loss.
TRX2 has world-class expertise and many years of experience in the field of potassium channel research and the molecular mechanism of male and female pattern hair loss. Please visit our Scientific Articles to view a selection of our publications and credentials in the field.
Supporters
Oxford BioLabs Ltd. received a grant award in 2009 from the National Council for Graduate Entrepreneurship (NGCE) Flying Start Entrepreneur fund. This fund was supported by the National Endowment for Science, Technology and the Arts (NESTA). For more information about NGCE and NESTA
NCGE – National Council For Graduate Entrepreneurship
The NCGE is a council group based on Birmingham, UK whose purpose is to develop and promote a culture of entrepreneurship through research, education and facilitation.
NESTA – the UK’s leading independent expert on innovation
NESTA works with public, private and third-sector partners bringing together powerful combinations of people, resources and bright ideas. NESTA combines capital investment with non-financial support to help the UK’s innovative early-stage companies turn their ideas into commercial success.
Readers who are searching Internet for info about the topic of how to loose weight quickly, then please make sure to visit the web site that was mentioned in this paragraph.